15-22851830-G-A
Position:
Variant summary
Our verdict is Benign. Variant got -15 ACMG points: 2P and 17B. PP3_ModerateBP6_Very_StrongBP7BA1
The NM_030922.7(NIPA2):c.99G>A(p.Lys33=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.184 in 1,609,850 control chromosomes in the GnomAD database, including 29,321 homozygotes. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.21 ( 3450 hom., cov: 31)
Exomes 𝑓: 0.18 ( 25871 hom. )
Consequence
NIPA2
NM_030922.7 synonymous
NM_030922.7 synonymous
Scores
1
1
Clinical Significance
Conservation
PhyloP100: 0.595
Genes affected
NIPA2 (HGNC:17044): (NIPA magnesium transporter 2) This gene encodes a possible magnesium transporter. This gene is located adjacent to the imprinted domain in the Prader-Willi syndrome deletion region of chromosome 15. Alternate splicing results in multiple transcript variants. Pseudogenes of this gene are found on chromosomes 3, 7 and 21.[provided by RefSeq, May 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -15 ACMG points.
PP3
BayesDel_noAF computational evidence supports a deleterious effect, 0.31
BP6
Variant 15-22851830-G-A is Benign according to our data. Variant chr15-22851830-G-A is described in ClinVar as [Benign]. Clinvar id is 1221596.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.595 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.301 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NIPA2 | NM_030922.7 | c.99G>A | p.Lys33= | synonymous_variant | 4/8 | ENST00000337451.8 | NP_112184.4 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NIPA2 | ENST00000337451.8 | c.99G>A | p.Lys33= | synonymous_variant | 4/8 | 5 | NM_030922.7 | ENSP00000337618 | P1 |
Frequencies
GnomAD3 genomes AF: 0.206 AC: 31192AN: 151644Hom.: 3442 Cov.: 31
GnomAD3 genomes
AF:
AC:
31192
AN:
151644
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.215 AC: 53577AN: 249672Hom.: 6574 AF XY: 0.208 AC XY: 28027AN XY: 135024
GnomAD3 exomes
AF:
AC:
53577
AN:
249672
Hom.:
AF XY:
AC XY:
28027
AN XY:
135024
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.181 AC: 264482AN: 1458086Hom.: 25871 Cov.: 32 AF XY: 0.181 AC XY: 131596AN XY: 725452
GnomAD4 exome
AF:
AC:
264482
AN:
1458086
Hom.:
Cov.:
32
AF XY:
AC XY:
131596
AN XY:
725452
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.206 AC: 31230AN: 151764Hom.: 3450 Cov.: 31 AF XY: 0.207 AC XY: 15388AN XY: 74170
GnomAD4 genome
AF:
AC:
31230
AN:
151764
Hom.:
Cov.:
31
AF XY:
AC XY:
15388
AN XY:
74170
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
776
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | GeneDx | May 04, 2021 | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
NIPA2-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Aug 30, 2024 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Pathogenic
CADD
Benign
DANN
Benign
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at